Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telaprevir + SOC in HCV Genotype 1 with HCC
NCT01821963Phase 3Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Apr 2013
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of telaprevir in hepatitis C (HCV), sponsored by University of Texas MD Anderson Cancer Center. Started Apr 2013; status: terminated.
02
Drugs
telaprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01821963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01821963.